Brian Mazzarella, MD, discusses the landscape for intermediate-risk prostate cancer and early VAPOR 2 findings on water vapor ablation.
Commentary|Videos|July 7, 2026
Updated AUA/SUO Advanced Prostate Cancer guideline emphasizes role of PSMA-PET
Author(s)Kristen R. Scarpato, MD, MPH
Fact checked by: Hannah Clarke, Tracy Ann Politowicz
Kristen Scarpato, MD, discusses 2026 AUA/SUO Advanced Prostate Cancer Guideline amendment recommendations on the use of PSMA-PET imaging for staging and treatment selection.
Advertisement
Advertisement
In this interview, Kristen R. Scarpato, MD, MPH, discusses 2026 American Urological Association (AUA)/Society of Urologic Oncology (SUO) Advanced Prostate Cancer Guideline amendment recommendations regarding the role of prostate-specific membrane antigen (PSMA)-PET imaging across the prostate cancer continuum, highlighting its impact on disease detection, treatment decision-making, and ongoing questions surrounding its clinical implications.1 Scarpato is an associate professor of urology at Vanderbilt University Medical Center in Nashville, Tennessee.
Related to this article
Juan Gómez-Rivas, MD, discusses barriers to PSMA-PET imaging and how disparities in access may affect prostate cancer staging and treatment planning.
Exploratory analyses suggest persistent immune remodeling after aglatimagene plus radiation in localized prostate cancer.
John P. Sfakianos, MD, discusses how ctDNA can be optimally integrated into bladder cancer clinical trials.
The phase 3 BiPASS trial is evaluating the use of 68Ga-PSMA-PET in combination with MRI for pre-biopsy prostate cancer detection.
In RTOG 3506, adding enzalutamide to standard ADT and salvage radiotherapy was associated with 2-year PFS benefit.
Armine K. Smith, MD, discusses the importance of integrating sexual health into bladder cancer care, including proactive counseling, preservation strategies, and multidisciplinary support.
In the phase 3 PACE-A trial, SBRT and prostatectomy showed similar 8-year disease control in localized prostate cancer, with lower rates of urinary incontinence after SBRT.
Advertisement
Advertisement